Zacks Research Research Analysts Decrease Earnings Estimates for Humana Inc. (NYSE:HUM)

Humana Inc. (NYSE:HUM) – Investment analysts at Zacks Research dropped their Q1 2024 earnings per share (EPS) estimates for shares of Humana in a research report issued to clients and investors on Wednesday, August 30th. Zacks Research analyst D. Chatterjee now expects that the insurance provider will earn $10.07 per share for the quarter, down from their prior estimate of $10.15. The consensus estimate for Humana’s current full-year earnings is $28.25 per share. Zacks Research also issued estimates for Humana’s Q2 2024 earnings at $9.28 EPS, Q3 2024 earnings at $7.86 EPS, Q4 2024 earnings at $4.46 EPS, Q1 2025 earnings at $10.66 EPS, Q2 2025 earnings at $10.09 EPS and FY2025 earnings at $37.09 EPS.

Humana (NYSE:HUM) last posted its quarterly earnings results on Wednesday, August 2nd. The insurance provider reported $8.94 earnings per share for the quarter, topping the consensus estimate of $8.88 by $0.06. The company had revenue of $26.75 billion for the quarter, compared to the consensus estimate of $25.83 billion. Humana had a return on equity of 20.70% and a net margin of 3.42%. The firm’s quarterly revenue was up 13.0% compared to the same quarter last year. During the same quarter in the prior year, the business posted $8.67 EPS.

Several other equities analysts have also recently weighed in on HUM. Mizuho lowered their price target on Humana from $615.00 to $550.00 in a report on Tuesday, July 11th. Truist Financial raised their target price on Humana from $530.00 to $550.00 and gave the stock a “hold” rating in a report on Thursday, August 3rd. Stephens raised their target price on Humana from $555.00 to $560.00 and gave the stock an “overweight” rating in a report on Thursday, August 3rd. TD Cowen decreased their target price on Humana from $616.00 to $613.00 and set an “outperform” rating on the stock in a report on Tuesday, August 15th. Finally, Deutsche Bank Aktiengesellschaft raised their target price on Humana from $468.00 to $628.00 and gave the stock a “buy” rating in a report on Monday, August 7th. Four equities research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $592.30.

Humana Stock Performance

Shares of HUM opened at $460.41 on Friday. The business’s fifty day simple moving average is $463.26 and its two-hundred day simple moving average is $489.44. The company has a current ratio of 1.37, a quick ratio of 1.37 and a debt-to-equity ratio of 0.58. Humana has a 12 month low of $423.29 and a 12 month high of $571.30. The company has a market cap of $57.05 billion, a price-to-earnings ratio of 17.18, a P/E/G ratio of 1.24 and a beta of 0.67.

Institutional Trading of Humana

A number of large investors have recently modified their holdings of HUM. Sunbelt Securities Inc. bought a new position in Humana during the 1st quarter worth about $28,000. WFA of San Diego LLC bought a new position in Humana during the 2nd quarter worth about $29,000. Gradient Investments LLC grew its holdings in Humana by 50.0% during the 2nd quarter. Gradient Investments LLC now owns 69 shares of the insurance provider’s stock worth $31,000 after acquiring an additional 23 shares in the last quarter. MV Capital Management Inc. grew its holdings in Humana by 40.8% during the 1st quarter. MV Capital Management Inc. now owns 69 shares of the insurance provider’s stock worth $33,000 after acquiring an additional 20 shares in the last quarter. Finally, Larson Financial Group LLC boosted its holdings in shares of Humana by 81.0% in the 2nd quarter. Larson Financial Group LLC now owns 76 shares of the insurance provider’s stock valued at $34,000 after buying an additional 34 shares in the last quarter. Hedge funds and other institutional investors own 91.86% of the company’s stock.

Humana Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, October 27th. Investors of record on Friday, September 29th will be issued a $0.885 dividend. The ex-dividend date of this dividend is Thursday, September 28th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 0.77%. Humana’s payout ratio is 13.21%.

About Humana

Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.